Xijing Yan

A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma.

Y. Chong, Wei Liu, Danyang Li, 2020, Genomics.

Identify Key Genes Correlated to Ischemia-Reperfusion Injury in Aging Livers

Jiahao Chen, Jinliang Liang, Jun Zheng, 2023, Disease markers.

CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect

Haitian Chen, Yang Li, Qi Zhang, 2023, Journal of Experimental & Clinical Cancer Research.

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Yefeng Zheng, Guihua Chen, Kai Ma, 2020, Journal of Cancer Research and Clinical Oncology.

Systemic analysis of the prognostic significance and interaction network of miR-26b-3p in cholangiocarcinoma.

Jinliang Liang, Rong Li, Xuejiao Li, 2023, Applied biochemistry and biotechnology.

Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways

Jinliang Liang, Rong Li, Jia Yao, 2023, Cell death discovery.

Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma

Guanxing Chen, Xijing Yan, Linsen Ye, 2024, Biomolecules & biomedicine.

Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling.

Wei Liu, Jinliang Liang, Rong Li, 2024, Cancer letters.